Resource List
ANIMAL Resource
BRC No. Type Strain Name Gene(s) Research Application(s)
RBRC02582 Inbred 129/SvEv
RBRC02458 Targeted Mutation B6.129-Adcyap1
RBRC02431 Targeted Mutation B6.129-Drd2 Drd3 Drd4
RBRC02439 Targeted Mutation B6.129-Drd2 Drd4
RBRC01084 Targeted Mutation B6.129-Drd5 Drd5 (dopamine receptor 5),
Ecogpt (E.coli xanthine phosphoribosyltransferase),
neo (neomycin resistance gene (E. coli))
RBRC01080 Targeted Mutation B6.129S-Drd1a<tm1Mok> Drd1a (dopamine receptor D1A),
Ecogpt (E.coli xanthine phosphoribosyltransferase),
neo (neomycin resistance gene (E. coli))
RBRC02438 Targeted Mutation B6.129S-Drd1a Drd3 Drd5
RBRC02440 Targeted Mutation B6.129S-Drd1a Drd5
RBRC01081 Targeted Mutation B6.129S-Drd2<tm1Mok> Drd2 (dopamine receptor 2),
neo (neomycin resistance gene (E. coli))
RBRC02454 Targeted Mutation B6.129S-Drd2/Q
RBRC01082 Targeted Mutation B6.129S-Drd3<tm1Mok> Drd3 (dopamine receptor 3),
Ecogpt (E.coli xanthine phosphoribosyltransferase),
neo (neomycin resistance gene (E. coli))
RBRC01083 Targeted Mutation B6.129S-Drd4<tm1Mok> Drd4 (dopamine receptor 4),
Ecogpt (E.coli xanthine phosphoribosyltransferase),
neo (neomycin resistance gene (E. coli))
RBRC01088 Targeted Mutation B6.129S-Hras1<tm1Mok> Hras1 (Harvey rat sarcoma virus oncogene 1),
neo (neomycin resistance gene (E. coli))
Cancer Research
RBRC02451 Targeted Mutation B6.129S-Hras1/Q
RBRC02259 Targeted Mutation B6.129S-Kras<tm1Mok> Kras (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog),
neo (neomycin resistance gene (E. coli))
Cancer Research
RBRC01089 Targeted Mutation B6.129S-Nras<tm1Mok> Nras (neuroblastoma ras oncogene),
neo (neomycin resistance gene (E. coli))
Cancer Research
RBRC02260 Targeted Mutation B6.129S-Trp53 Trp53 (transformation-related protein 53),
lacZ (beta-galactosidase (E. coli))
Cancer Research,
Cell Biology Research,
Immunology and Inflammation Research,
Mouse Models for Human Disease,
Fluorescent Proteins/lacZ System
RBRC02257 Targeted Mutation B6.129S2-Grin2b<tm1Stl> Grin2b (glutamate receptor, ionotropic, NMDA2B (epsilon 2)),
neo (neomycin resistance gene (E. coli))
RBRC02374 Targeted Mutation B6.129S4-Cav3/177 Cav3 (caveolin 3),
neo (neomycin resistance gene (E. coli))
RBRC02268 Targeted Mutation B6.129S4-Sgcb<tm1Oza> Sgcb (sarcoglycan, beta (dystrophin-associated glycoprotein)),
neo (neomycin resistance gene (E. coli))
RBRC02269 Targeted Mutation B6.129S4-Sgcg<tm1Oza> Sgcg (sarcoglycan, gamma (dystrophin-associated glycoprotein)),
neo (neomycin resistance gene (E. coli))
RBRC02484 Targeted Mutation and Transgene B6.Cg-B6.Cg-Hras1 Nras Tg(HRAS/floxed)1Mok
RBRC02522 Targeted Mutation Congenic B6.Cg-Drd1a Drd1a Tg(TRE-Drd1a/lacZ)1Mok Drd1a (dopamine receptor D1A),
lacZ (beta-galactosidase (E. coli)),
neo (neomycin resistance gene (E. coli)),
tTA (tTA (E. coli tet repressor (TetR), herpes simplex virus (HSV) VP16 activation domain))
Tet system,
Fluorescent Proteins/lacZ System
RBRC02419 Targeted Mutation Congenic B6.Cg-Drd1a Drd2
RBRC02571 Targeted Mutation B6.Cg-Drd1a Drd2
RBRC02523 Targeted Mutation Congenic B6.Cg-Drd1a Drd2 Drd1a Tg(TRE-Drd1a/lacZ)1Mok Drd1a (dopamine receptor D1A),
Drd2 (dopamine receptor 2),
lacZ (beta-galactosidase (E. coli)),
neo (neomycin resistance gene (E. coli)),
tTA (tTA (E. coli tet repressor (TetR), herpes simplex virus (HSV) VP16 activation domain))
Tet system,
Fluorescent Proteins/lacZ System
RBRC02583 Targeted Mutation B6.Cg-Drd1a Drd2 Tg(EGFP)
RBRC02475 Targeted Mutation Congenic B6.Cg-Hras1 Nras Il6st
RBRC02485 Targeted Mutation and Transgene B6.Cg-Hras1 Nras Kras Tg(HRAS/floxed)1Mok HRAS (Harvey rat sarcoma virus oncogene (human)),
Hras (Harvey rat sarcoma virus oncogene),
Kras (v-Ki-ras2 Kirsten rat sarcome viral oncogene homolog),
Nras (neuroblastoma ras oncogene),
loxP (phage P1 loxP)
RBRC02466 Targeted Mutation B6.Cg-Hras1 Src
RBRC02460 Targeted Mutation and Transgene B6.Cg-Hras1 Tg(cre) Tg(lacZ) Hras1 (Harvey rat sarcoma virus oncogene 1),
cre (Phage P1 Cre recombinase),
lacZ (beta-galactosidase (E. coli)),
neo (neomycin resistance gene (E. coli))
RBRC02481 Targeted Mutation and Transgene B6.Cg-Hras1 Tg(HRAS)2Mok Tg(Hras)1Mok
RBRC02474 Targeted Mutation Congenic B6.Cg-Htr1b
RBRC02572 Targeted Mutation Congenic B6.Cg-Htr1b
RBRC02487 Targeted Mutation B6.Cg-Il6st Hras1
RBRC02488 Targeted Mutation B6.Cg-Il6st Hras1 Nras
RBRC02486 Targeted Mutation B6.Cg-Il6st Nras
RBRC02476 Targeted Mutation Congenic B6.Cg-Kras Il6st Il6st (interleukin 6 signal transducer),
Kras (v-Ki-ras2 Kirsten rat sarcome viral oncogene homolog)
RBRC02427 Targeted Mutation and Transgene B6.Cg-Kras Tg(hKrasPAC)1Mok KRAS (v-Ki-ras2 Kirsten rat sacroma viral oncogene homolog (human)),
Kras (v-Ki-ras2 Kirsten rat sacroma viral oncogene homolog),
neo (neomycin resistance gene (E. coli))
RBRC02441 Targeted Mutation and Transgene B6.Cg-Kras Tg(HRAS/floxed)1Mok HRAS (Harvey rat sarcoma virus oncogene (human)),
Kras (v-Ki-ras2 Kirsten rat sarcome viral oncogene homolog),
loxP (phage P1 loxP)
RBRC02428 Targeted Mutation and Transgene B6.Cg-Kras Trp53 Tg(hKrasPAC)1Mok KRAS (v-Ki-ras2 Kirsten rat sacroma viral oncogene homolog (human)),
Kras (v-Ki-ras2 Kirsten rat sacroma viral oncogene homolog),
Trp53 (transformation related protein 53),
lacZ (beta-galactosidase (E. coli)),
neo (neomycin resistance gene (E. coli))
Cancer Research,
Cell Biology Research,
Immunology and Inflammation Research,
Mouse Models for Human Disease
RBRC02483 Targeted Mutation and Transgene B6.Cg-Nras Tg(HRAS/floxed)1Mok
RBRC02469 Targeted Mutation Congenic B6.Cg-Prnp
RBRC02459 Transgene Congenic B6.Cg-Tg(hKrasPAC)1Mok
RBRC02267 Transgene Congenic B6.Cg-Tg(HRAS)2Mok HRAS (Harvey rat sarcoma virus oncogene (human)) Cancer Research
RBRC02524 Transgene Congenic and Spontaneous Mutation B6.Cg-Tg(HRAS)2Mok Kit
RBRC02448 Transgene and Spontaneous Mutation B6.Cg-Tg(HRAS)2Mok Kit Kit
RBRC02525 Transgene Congenic B6.Cg-Tg(HRAS)2Mok Kit
RBRC02471 Transgene Congenic B6.Cg-Tg(HRAS/floxed)1Mok
RBRC02464 Transgene Congenic B6.Cg-Tg(Hras/HRAS)1Mok
RBRC02430 Transgene Congenic B6.Cg-Tg(HRAS/pBS302)1Mok
RBRC02452 Transgene Congenic B6.Cg-Tg(KRAS)1Mok Kras (v-Ki-ras2 Kirsten rat sacroma viral oncogene homolog (human))
RBRC02482 Transgene Congenic B6.Cg-Tg(MBP)561Mok Tg(MBPas)1Mok
RBRC02480 Transgene Congenic B6.Cg-Tg(MBP)563Mok Tg(MBPas)1Mok
RBRC02465 Transgene Congenic B6.Cg-Tg(rpsL)1Mok
RBRC02584 Targeted Mutation B6;129-Drd1a Drd2 Drd3 Drd4 Drd5
RBRC02470 Targeted Mutation B6;129-Drd2 Drd4
RBRC02478 Targeted Mutation B6;129-Grin2a Drd2 Drd3 Drd4
RBRC02477 Targeted Mutation B6;129-Grin2a Grin2b Drd2 Drd3 Drd4
RBRC02467 Targeted Mutation B6;129-Hprt1 Hprt1 (hypoxanthine guanine phosphoribosyl transferase),
neo (neomycin resistance gene)
RBRC02598 Targeted Mutation B6;129-Mutyh Mutyh (mutY homolog (E. coli)),
neo (neomycin resistance gene)
Neurobiology Research
RBRC02258 Targeted Mutation B6;129S(Cg)-Grin2c Grin2c (glutamate receptor, ionotropic, NMDA2C (epsilon 3)),
neo (neomycin resistance gene (E. coli))
RBRC05834 Targeted Mutation B6;129S-Dmd Dmd (dystrophin, muscular dystrophy),
neo (neomycin resistance gene (E. coli))
RBRC02457 Targeted Mutation B6;129S-Drd2 Drd3
RBRC02255 Targeted Mutation B6;129S-Grin1<tm1Nak> Grin1 (glutamate receptor, ionotropic, NMDA1 (zeta 1)),
neo (neomycin resistance gene (E. coli))
RBRC02256 Targeted Mutation B6;129S-Grin2a<tm1Nak> Grin2a (glutamate receptor, ionotropic, NMDA2A (epsilon 1)),
neo (neomycin resistance gene (E. coli))
RBRC02472 Targeted Mutation B6;129S-Grin2a Grin2b
RBRC02473 Targeted Mutation B6;129S-Grin2a Hras1
RBRC02479 Targeted Mutation B6;129S-Hras1 Grin2a Drd1a Drd5
RBRC02468 Targeted Mutation B6;129S-Irf3/Mok
RBRC05650 Targeted Mutation B6;129S-Zrsr1 Zrsr1 (zinc finger (CCCH type), RNA binding motif and serine/arginine rich 1),
neo (neomycin resistance gene (E. coli))
RBRC02375 Targeted Mutation B6;129S4-Cav3/32 Cav3 (caveolin 3),
neo (neomycin resistance gene (E. coli))
RBRC02376 Targeted Mutation B6;129S4-Cav3/142 Cav3 (caveolin 3),
neo (neomycin resistance gene (E. coli))
RBRC02377 Targeted Mutation B6;129S4-Cav3/177 Cav3 (caveolin 3),
neo (neomycin resistance gene (E. coli))
RBRC02585 Targeted Mutation C.Cg-Drd3
RBRC02586 Targeted Mutation C.Cg-Hras
RBRC02426 Targeted Mutation Congenic C3.Cg-Drd1a Drd2 Drd1a (dopamine receptor D1A),
Drd2 (dopamine receptor 2),
neo (neomycin resistance gene (E. coli))
RBRC02453 Targeted Mutation Congenic C3.Cg-Drd2/Q
RBRC02429 Targeted Mutation Congenic C3.Cg-Drd2 Drd3 Drd4 Drd2 (dopamine receptor 2),
Drd3 (dopamine receptor 3),
Drd4 (dopamine receptor 4),
neo (neomycin resistance gene (E. coli))
RBRC02450 Targeted Mutation Congenic C3.Cg-Hras1/Q
RBRC02456 Targeted Mutation C57BL/6-Kit
RBRC02526 Spontaneous Mutation C57BL/6-Kit
RBRC02425 Targeted Mutation CBy.Cg-Drd1a Drd2 Drd1a (dopamine receptor D1A),
Drd2 (dopamine receptor 2),
Ecogpt (E.coli xanthine phosphoribosyltransferase),
neo (neomycin resistance gene (E. coli))
RBRC02455 Targeted Mutation CBy.Cg-Drd2/Q
RBRC02447 Targeted Mutation CBy.Cg-Drd2 Drd3 Drd4
RBRC02449 Targeted Mutation CBy.Cg-Hras1/Q
RIKEN BioResource Center